- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06125145
Geriatric Assessment and Promotores (GAP) Pilot Feasibility Study (GAP)
Tailored Geriatric Assessment and Promotores Pilot Feasibility Study
The goal of this clinical trial is to test a new way to help older adults who have had cancer.
The researchers want to see if a program that assesses participants health and aging is achievable and makes a difference. A community health worker/promotora de salud will assess their health and provide coaching to help them feel better. This is important because older adults with cancer often have other health issues that are not addressed after completing treatment. The researchers want to make sure they get the care they need.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Sacramento, California, United States, 95817
- University of California, Davis
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 65-90
- Able to understand study procedures and to comply with them for the entire length of the study.
- Diagnosis of Stage II-III breast, colorectal, or prostate cancer in within 1 to 24 months.
- Completed course of definitive therapy within 12 months from enrollment into the study.
- Proficient in English or Spanish
- Reside within the UC Davis Health catchment area.
- Has self-reported primary caregiver aged 21-90 years.
Exclusion Criteria:
- Contraindication to any study-related procedure or assessment.
- Patient is unable to independently deliver informed consent.
- Patient screens positive for cognitive impairment (6CIT > 8)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Feasibility Arm
All enrolled participants will receive the pilot Geriatric Assessment and Promotora Coaching intervention.
|
In Visit 1 the community health worker/promotora will assess frailty, cognition, polypharmacy, depression, symptom burden, and social support.
In Visits 2 and 3 the community health worker will deliver interpersonal communication techniques to deliver the problem solving coaching format, leverage cultural congruence with clients, and provide social support to assist in adopting healthy behaviors.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Describe the percentage of participants that complete 2 out of 3 study visits
Time Frame: 6 month
|
Calculate percentage of participants that complete study compared to total enrolled (Goal: 65)
|
6 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical Function
Time Frame: Baseline to 6 month
|
Patient-Reported Outcomes Measurement Information System [PROMIS] Physical Function
|
Baseline to 6 month
|
|
Depression, Anxiety, and Fatigue
Time Frame: Baseline to 6 month
|
Patient-Reported Outcomes Measurement Information System [PROMIS] Depression, Anxiety, and Fatigue
|
Baseline to 6 month
|
|
Self-Efficacy
Time Frame: Baseline to 6 month
|
Patient-Reported Outcomes Measurement Information System [PROMIS] Self-Efficacy
|
Baseline to 6 month
|
|
Emotional Support
Time Frame: Baseline to 6 month
|
Patient-Reported Outcomes Measurement Information System [PROMIS] Emotional Support
|
Baseline to 6 month
|
|
Quality of Life in Elderly Cancer Patients
Time Frame: Baseline to 6 month
|
European Organization for Research and Treatment of Cancer [EORTC] Quality of Life Questionnaire in the Elderly 14 item questionnaire [QLQ-ELD14].
Range 0 to 100, higher scores indicate better quality of life.
|
Baseline to 6 month
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Alex Fauer, PhD MS, UC Davis
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Urogenital Diseases
- Genital Diseases
- Pathologic Processes
- Genital Neoplasms, Male
- Urogenital Neoplasms
- Neoplasms by Site
- Neoplasms
- Genital Diseases, Male
- Prostatic Diseases
- Male Urogenital Diseases
- Intestinal Diseases
- Gastrointestinal Neoplasms
- Digestive System Neoplasms
- Digestive System Diseases
- Gastrointestinal Diseases
- Intestinal Neoplasms
- Rectal Diseases
- Colonic Diseases
- Skin Diseases
- Breast Diseases
- Pathological Conditions, Signs and Symptoms
- Skin and Connective Tissue Diseases
- Frailty
- Prostatic Neoplasms
- Colorectal Neoplasms
- Breast Neoplasms
- Health Care Quality, Access, and Evaluation
- Investigative Techniques
- Epidemiologic Methods
- Data Collection
- Health Care Evaluation Mechanisms
- Quality of Health Care
- Public Health
- Environment and Public Health
- Population Characteristics
- Health Status
- Demography
- Epidemiologic Measurements
- Geriatric Assessment
Other Study ID Numbers
- 1943526
- 5K12CA138464 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States
-
University of Colorado, DenverCompletedStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast CancerUnited States
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerCanada
-
Mayo ClinicMarker Therapeutics, Inc.CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
University of Central FloridaFlorida Department of HealthRecruitingBreast Cancer | Breast Cancer Female | Breast Cancer Diagnosis | Breast Cancer Survivors | Breast Cancer Detection | Breast Cancer AwarenessUnited States
Clinical Trials on Geriatric Assessment and Promotora Coaching
-
Supriya MohilePatient-Centered Outcomes Research Institute; National Cancer Institute (NCI)CompletedLymphoma | Adult Solid NeoplasmUnited States
-
Peking University People's HospitalNot yet recruitingElderly | ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION | Geriatric AssessmentChina
-
University of California, San FranciscoRecruiting
-
Centre Francois BaclesseCompletedProstate Cancer Cured | Healthy Population ControlFrance
-
Ottawa Hospital Research InstituteCompletedMortality | Aged | Epidemiology | SURGICAL PROCEDURES, OPERATIVECanada
-
Memorial Sloan Kettering Cancer CenterCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
Supriya MohileNational Cancer Institute (NCI); University of Chicago; City of Hope National...CompletedLymphoma | Toxicity | Adult Solid NeoplasmUnited States
-
Université Catholique de LouvainCHU UCL NamurNot yet recruitingGeriatric Assessment | Nursing Home ResidentBelgium
-
University of CagliariUniversità degli Studi di Ferrara; University of Milano BicoccaRecruitingDiabetes | Older PeopleItaly
-
University Hospital, CaenRecruiting